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c-fos gene expression in two types of mouse sarcoma cells of spontaneous origin and in revertants to pseudonormal phenotype has been investigated. 
In the latter cells the content of c-fos mRNA is similar to that in normal fibroblasts. Activity of transcription factors interacting with the regulatory 
elements, SRE, DSE and TRE, in the c-fos promoter do not correlate with the c-fos mRNA concentration. However, experiments with cells 
transformed with the indicator plasmid, fos-CAT, showed that the 600 bp c-fos promoter region provides the chloramphenicol acetyhransferase 
activity correlating with c-fos mRNA expression in cell revertants to a pseudonormal phenotype. 
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1. INTRODUCTION 
The c-fos gene is an immediate arly gene, and serves 
as a marker of transition from a quiescent o a mitotic 
state of a cell in response to growth stimuli [l]. There- 
fore, investigation of the regulation of this gene in cells 
in response to different growth stimuli may shed some 
light on characteristic features of cells which differ in 
their tumorigenic potential. We investigated C-$X ex- 
pression in two lines of spontaneously transformed em- 
bryonic fibroblasts of mice, CBA and C3H. Each of 
these lines was represented by a pair of clones: tumo- 
rigenic, and non-tumorigenic, obtained from the first 
one as a result of reversion from a transformed pheno- 
type to a pseudonormal one in the process of cloning [2]. 
The clones differed in their tumorigenicity and their 
response to growth stimuli. Like normal fibroblasts, 
non-tumorigenic ells possess the property of density- 
dependent growth arrest in monolayer culture and 
could be stimulation by different growth factors. Tumo- 
rigenic cells do not respond to the stimulation [2]. 
selected for neomycin resistance in medium containing G418 (500 
pg/ml). Individual clones were isolated, amplified, and characterized 
for the incorporation and expression of the construct by Southern blot 
analysis and CAT (chloramphenicol acetyltransferase) activity, as de- 
scribed in [S]. The plasmid, fos-cat. was constructed by inserting the 
HindlII-NurI (600 bp) fragment of the mouse c-fos gene and CAT 
gene (ClaI-BumHI) in the PBS plasmid (Stratagene) in the HmdIII- 
BumHI sites. The control plasmid for testing the transient ransfection 
efficiency contained the LTR on the ROW sarcoma virus and CAT 
gene. RNA was isolated as described in [6]. Northern blot analysis was 
performed according to [7]. As a probe, a PsrI-PsrI fragment of the 
v-fos (1,000 bp) was used. Specific radioactivity of the probe was 
5 x lo8 cpm&g. 
Ohgonucleotides: DSE (5’-[32P]-AGCTTGATGCCCATATTAG- 
GACATCTA), TRE (5’-[“PI-GATCCATGAGTCAGAG), SRE (S- 
[32P]-CGGATGTCCATATTAGGACATCTGCGTCAGCAG) were 
synthesized by standard automated methods and purified by poly- 
acrylamide gel electrophoresis followed by reverse-phase liquid col- 
umn chromatography (Silasorb-C8, O-50% gradient of acetonitrile 
with 20 mM LiCIO,). Nuclear extracts were prepared as described in 
[8]. For the binding assay, typically, 5pg of protein was incubated with 
1 ng (10,000 cpm) of a radiolabeled oligonucleotide. The complexes 
formed were analyzed by electrophoresis n 5% polyacrylamide gels. 
3. RESULTS AND DISCUSSION 
2. MATERIALS AND METHODS 
Cells were grown in Dulbecco’s modified Eagle’s medium supple- 
mented with 10% fetal calf serum (FCS). Transfection of cells was 
performed by the calcium phosphate-mediated precipitation method 
[3]. Retardation of cell growth was achieved by cultivation in DMEM 
with 0.5% embryonal serum for 48 h, followed by serum starvation for 
36 h. Stimulation was performed by incubation in 20% FCS or TPA 
(5 nM). For stable transfection, cells were co-transfected with the 
plasmids, fos-CAT and pSV2neo [4], at a ratio of 10: 1. The cells were 
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The cells investigated in this work represented two 
lines of aggressive sarcoma. These cells were obtained 
from mice fibroblasts, C3H and CBA, by spontaneous 
transformation in vitro, and then re-cloned 6 times. 
After each re-cloning, the cells were tested for the ability 
to produce tumors in singene mice (test for tumorigen- 
icity). Most of the clones were formed by the parent 
aggressive cells, which were non-sensitive to growth fac- 
tors and showed no contact inhibition. However, at 
each recloning about 15% of revertants were obtained 
which were sensitive to growth factors and showed con- 
tact inhibition [2]. These cell lines may be an interesting 
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Fig. 1. Determination of c-fos mRNA content in cells. (Lanes 14) Fibroblasts of mice CBA. (Lanes 5-8) Fibroblasts of mice C3H. (Lanes 1.5) 
Quiescent non-tumorigenic ells (48 h in the serum-free medium); (2,8) quiescent non-tumorigenic ells incubated with 20% FCS for 30 min; (3.6) 
non-tumorigenic ells in log-phase of growth; (4,7) tumorigenic ells. 
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Fig. 2. Regulatory sites of the c-fos promoter in thefos-CAT plasmid. 
SIS, PDGF control element; DSE, double symmetry element; SRE, 
serum response lement; TRE, TPA response lement; Rb, retinoblas- 
tome control element; CAT, the start of the gene coding for chloram- 
phenicol acetyltransferase. 
model for investigation of mechanisms of malignant 
transformation of cells, because they give the possibility 
of investigating both spontaneous transformation and 
normalization of the cellular phenotype. 
In this study the following cells were investigated: (i) 
tumor cells, obtained from fibroblasts of mice C3H; (ii) 
non-tumorigenic revertants obtained from the above 
cells; (iii) tumor cells, obtained from fibroblasts of mice 
CBA; (iv) non-tumorigenic revertants, obtained from 
the above cells (iii). Cells (i) and (iii) have a highly 
transformed phenotype; cells (ii) and (iv) have a pseu- 
donormal phenotype. Fig. 1 shows the results of assay 
of c-fos mRNA content in the above cells under differ- 
ent conditions, namely in quiescent, stimulated and pro- 
liferating non-tumorigenic ells and in malignant cells, 
which can only be sustained by growing, and die at low 
concentrations of the serum. After 30 min stimulation 
of the quiescent cells with embryonal serum or TPA, a 
considerable amount of the mRNA was detected in the 
cells (Fig. 1). This result is in accordance with the data 
on c-fos regulation in normal fibroblasts [9]. The con- 
tent of c-fos mRNA in the quiescent pseudonormal cells 
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Fig. 3. CAT assay in extracts from C3H cells 48 h after transfection withfos-CAT plasmid. (Lane 1) Quiescent non-tumorigenic ells incubated 
with 20% FCS for 3 h; (2) quiescent non-tumorigenic ells, 48 h in serum-free medium; (3) non-tumorigenic ells in log-phase of growth; 
(4) non-tumorigenic ells in log-phase of growth incubated with 20% FCS for 3 h; (5) quiescent non-tumorigenic ells Incubated with TPA for 3 
h; (6) tumorigemc ells. 
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Fig. 4. CAT assay in extracts from C3H cells stably transfected with 
fos-CAT plasmid. (Lane 1) Quiescent non-tumorigenic ells incubated 
with 20% FCS for 3 h; (2) non-tumorigenic ells in log-phase of 
growth; (3) quiescent non-tumorigenic ells. 
January 1993 
and in the malignant cells was too low to be detected by 
Northern hybridization under the conditions used. 
f- Ac.chloram 
We tried to find out whether the known regulatory 
phenicol 
elements of the c-fos gene promoter can provide the 
pattern of regulation of the indicator gene, CAT, similar 
to that observed for the c-fos gene in these cells. To this 
+---- chloramph 
aim, we have constructed a &-CAT plasmid (Fig. 2). 
Determination of CAT activity in quiescent and TPA- 
stimulated cells or FCS cells transiently transfected with 
the f&CAT plasmid, showed that the selected pro- 
moter fragment provides the CAT activity, correlating 
with the level of c-fos RNA in the cells (Figs. 1 and 3). 
Similar results were obtained with cells stably trans- 
fected with they&-CAT plasmid (Fig. 4). 
Since the major regulatory sites of the c-fos gene pro- 
moter region are shown [lo-l 51, we assayed the activity 
of the transcription factors interacting with these sites 
in the transformed and non-transformed cell lines. It 
was found that stimulation of synthesis of c-$x mRNA 
with TPA or embryonic serum in non-tumorigenic ells 
do not correlate with DSE, SRE and TRE transcription 
factor activities (Fig. 5). The data shown are for SRE; 
the same results were obtained for DSE and TRE. An 
increase in the c-fos mRNA concentration was observed 
15 min after cell stimulation, while an increase in the 
factors’ activity was detected 6 h later (data not shown). 
+---- free probe 
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Fig. 5. Gel-retardation of SRE oligonucleotide with nuclear extracts from C3H cells. (Lane 1) Quiescent non-tumorigenic; (2) quiescent non- 
tumorigenic, incubated with 20% FCS for 30 mitt; (3) quiescent non-tumorigenic, incubated with 20% FCS for 1 h; (4) quiescent non-tumorigenic, 
incubated with TPA for 30 min; (5) quiescent non-tumorigenic, incubated with TPA for 1 h; (6) non-tumorigenic in log-phase of growth; 
(7) tumorigenic. 
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Despite the different concentrations of c-fos mRNA. 
similar high levels of the factors’ activities were found 
in log-phase growth in transformed and non-trans- 
formed cells. The absence of a correlation between c-j& 
transcription and activity of the transcription factors 
interacting with SRE was demonstrated in the human 
cell line, A431 [16]. 
The results indicate that the investigated part of the 
c-f& promoter region is sufficient to provide the ob- 
served c-fos gene regulation pattern. The absence of 
correlation between c-fos mRNA concentrations and 
transcription factor activities may be explained either 
by some modification of the transcription factors affect- 
ing the regulation or by the existence of some other 
transcription factors or by regulation sites besides those 
tested [ 171. 
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